C07D 277/20
Having two or three double bonds between ring members or between ring
Official title: having two or three double bonds between ring members or between ring members and non-ring members
C07D277/20 (Having two or three double bonds between ring members or between ring) appears on 5,619 US grants and 4,922 published applications in this corpus.
Search patents in C07D- Granted patents
- 5,619
- Published applications
- 4,922
- Assignees
- 1,874
- Inventors
- 14,662
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 46 | 0 |
| 1977 | 68 | 0 |
| 1978 | 59 | 0 |
| 1979 | 52 | 0 |
| 1980 | 66 | 0 |
| 1981 | 81 | 0 |
| 1982 | 58 | 0 |
| 1983 | 79 | 0 |
| 1984 | 81 | 0 |
| 1985 | 62 | 0 |
| 1986 | 58 | 0 |
| 1987 | 63 | 0 |
| 1988 | 66 | 0 |
| 1989 | 67 | 0 |
| 1990 | 90 | 0 |
| 1991 | 93 | 0 |
| 1992 | 80 | 0 |
| 1993 | 123 | 0 |
| 1994 | 90 | 0 |
| 1995 | 93 | 0 |
| 1996 | 102 | 0 |
| 1997 | 121 | 0 |
| 1998 | 113 | 0 |
| 1999 | 120 | 0 |
| 2000 | 100 | 0 |
| 2001 | 151 | 28 |
| 2002 | 137 | 153 |
| 2003 | 139 | 252 |
| 2004 | 137 | 288 |
| 2005 | 120 | 262 |
| 2006 | 141 | 231 |
| 2007 | 153 | 230 |
| 2008 | 141 | 239 |
| 2009 | 137 | 271 |
| 2010 | 189 | 291 |
| 2011 | 166 | 233 |
| 2012 | 205 | 192 |
| 2013 | 170 | 209 |
| 2014 | 221 | 244 |
| 2015 | 197 | 205 |
| 2016 | 171 | 199 |
| 2017 | 165 | 183 |
| 2018 | 128 | 161 |
| 2019 | 140 | 138 |
| 2020 | 99 | 149 |
| 2021 | 97 | 131 |
| 2022 | 93 | 158 |
| 2023 | 72 | 158 |
| 2024 | 80 | 130 |
| 2025 | 86 | 114 |
| 2026 | 53 | 73 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- Polymorphs of Ponesimod15 Sep 2026US 12,735,391 B2Tapi Czech Industries S.R.O
- Arylsulfonamides as orexin receptor agonists8 Sep 2026US 12,729,178 B2Research Triangle Institute
- Crystalline forms of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof18 Aug 2026US 12,709,603 B2vTv Therapeutics LLC
- Compound and method for preventing or treating of respiratory diseases comprising the same as an active ingredient28 Jul 2026US 12,691,101 B2Yonsei University, University—Industry Foundation (Uif)
- Probenecid compounds for the treatment of inflammasome-mediated lung disease8 Oct 2026US 2026/0308131 A1Bacainn Biotherapeutics, Ltd.
- Therapeutic compounds1 Oct 2026US 2026/0297016 A1Regents of the University of Minnesota
- Biarylamide derivatives and their use as pkmyt1 inhibitors1 Oct 2026US 2026/0297042 A1Cancer Research Technology Limited
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Hiv-1p rotease inhibitors and uses thereof17 Sep 2026US 2026/0272926 A1Purdue Research Foundation
Most cited
By later US patents
- Phenyl heterocycles as cox-2 inhibitors281US 5,474,995 AMerck Frosst Canada, Inc. · 1995
- Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof277US 5,549,974 AAffymax Technologies N.V. · 1996
- Phenyl heterocycles as cox-2 inhibitors208US 5,550,142 AMerck Frosst Canada, Inc. · 1996
- Phenyl heterocycles as COX-2 inhibitors204US 5,536,752 AMerck Frosst Canada, Inc. · 1996
- Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase183US 5,409,944 AMerck Frosst Canada, Inc. · 1995